REVERSINE
UNII Z499CLJ023

Substance Identification & Data

This profile provides standardized clinical and technical data for Reversine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z499CLJ023.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 656820-32-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Z499CLJ023

CAS Registry Number

656820-32-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REVERSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H27N7O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZFLJHSQHILSNCM-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C223508

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

210332

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c(Nc2ccc(cc2)N3CCOCC3)nc4[nH]cnc4c1NC5CCCCC5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Reversine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.